Irinotecan Hydrochloride 25021-0230
Product NDC
25021-0230- Manufacturer
- Sagent Pharmaceuticals
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 15, 2014
- Application
- ANDA090675
Need to source Irinotecan Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Irinotecan Hydrochloride | 20 mg/mL |
Drug Class
Topoisomerase Inhibitor [EPC]Topoisomerase Inhibitors [MoA]
Packaging Options(2)
1 VIAL in 1 CARTON (25021-230-02) / 2 mL in 1 VIAL
1 VIAL in 1 CARTON (25021-230-05) / 5 mL in 1 VIAL